Retin-a and Valacyclovir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Retin-a (tretinoin) and Valacyclovir (valacyclovir hydrochloride). Common drug interactions include cognitive disorder among females and ocular icterus among males.

The phase IV clinical study analyzes what interactions people have when they take Retin-a and Valacyclovir. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Retin-a?

Retin-a has active ingredients of tretinoin. It is often used in acne. eHealthMe is studying from 2,475 Retin-a users. Check the latest studies of Retin-a.

What is Valacyclovir?

Valacyclovir has active ingredients of valacyclovir hydrochloride. It is often used in genital herpes. eHealthMe is studying from 42,108 Valacyclovir users. Check the latest studies of Valacyclovir.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

12 people who take Retin-a and Valacyclovir together, and have interactions are studied.

Retin-a and Valacyclovir drug interactions.

What are the common drug interactions of Retin-A and Valacyclovir, by gender? *:

female:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Iron deficiency
  3. Nasal septum deviation (deviated nasal septum)
  4. Pain
  5. Lymph node calcification (calcium deposit in lymph node)
  6. Silicosis (a lung disease that is caused by inhaling tiny bits of silica)
  7. Ulcer haemorrhage (bleeding ulcer)
  8. Adverse drug reaction
  9. Blood potassium decreased
  10. Erythema (redness of the skin)

male:

  1. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Blood creatinine increased
  5. Chronic kidney disease
  6. Emotional distress
  7. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  8. Pain
  9. Renal impairment (severely reduced kidney function)

What are the common drug interactions of Retin-A and Valacyclovir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  2. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  3. Sinusitis (inflammation of sinus)

30-39:

n/a

40-49:

  1. Iron deficiency
  2. Nasal septum deviation (deviated nasal septum)
  3. Pain
  4. Silicosis (a lung disease that is caused by inhaling tiny bits of silica)
  5. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  6. Accident at work
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood creatinine increased
  4. Chronic kidney disease
  5. Emotional distress
  6. Pain
  7. Renal impairment (severely reduced kidney function)

60+:

  1. Spinal column injury (spinal cord bone injury)

What are the existing conditions these people have? *

  1. Drowsiness: 5 people, 41.67%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 16.67%
  3. Multiple Myeloma (cancer of the plasma cells): 2 people, 16.67%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 16.67%
  5. Hiv Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Retin-a and Valacyclovir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Retin-a and Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Retin-a:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valacyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Retin-a and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valacyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tretinoin and valacyclovir hydrochloride (the active ingredients of Retin-a and Valacyclovir, respectively), and Retin-a and Valacyclovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: